Regeneron Pharmaceuticals REGN
NASDAQ REGN
$790.74 -5.60 (-0.70%)
At close: Oct 16, 2026 · 4:00 PM EDT

Regeneron Pharmaceuticals (REGN) Acquisitions (2023 - 2025)

Updated

Regeneron Pharmaceuticals (REGN) posted Acquisitions of $300,000 for Q4 2025, down 97.4% from $11.5 million a year earlier and down 90.0% from the prior quarter.

Analysis

Regeneron Pharmaceuticals (REGN) Acquisitions (2023 - 2025) Analysis & Trends

For FY2025, Regeneron Pharmaceuticals' Acquisitions came in at $3.3 million, down 80.0% from FY2024.

  • Annual Acquisitions has declined for three consecutive years, with a three-year compound annual growth rate of -75.7% (FY2022 to FY2025).
  • In prior years, Regeneron Pharmaceuticals' Acquisitions was $16.5 million in FY2024 (-69.9%), $54.9 million in FY2023 (-76.2%) and $230.3 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn -17.24 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn -
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn -
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn -
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 11.21 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn -
10 Regeneron Pharmaceuticals 81.27 Bn 47.47 Bn 3.71 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 300,000.00
Sep 30, 2025 3.00 Mn
Dec 31, 2024 11.50 Mn
Dec 31, 2023 3.80 Mn
Sep 30, 2023 51.10 Mn
API Access

Regeneron Pharmaceuticals Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=REGN&period=max&api_key=YOUR_API_KEY